HALO Raises 2025 Revenue to $1.39B, 36% YoY Growth, 2026 Guidance to $1.71-1.81B, Acquires Surf Bio for up to $400M
Halozyme Therapeutics, Inc. · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) · Now $66.54
Post-detection moves
1h
—
1d
—
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS